David Adams

Active 1948–2025

421
Papers
85,040
Citations
142
h-index
408
i10-index

Citations

Citations per year for David Adams1954: 2 citations1955: 1 citations1956: 1 citations1957: 2 citations1958: 1 citations1963: 2 citations1964: 1 citations1966: 2 citations1967: 1 citations1968: 1 citations1969: 1 citations1970: 2 citations1971: 1 citations1976: 1 citations1978: 4 citations1979: 1 citations1982: 1 citations1984: 3 citations1985: 1 citations1986: 3 citations1987: 6 citations1988: 7 citations1989: 11 citations1990: 19 citations1991: 12 citations1992: 22 citations1993: 49 citations1994: 111 citations1995: 132 citations1996: 159 citations1997: 149 citations1998: 170 citations1999: 206 citations2000: 193 citations2001: 203 citations2002: 242 citations2003: 214 citations2004: 216 citations2005: 229 citations2006: 203 citations2007: 247 citations2008: 345 citations2009: 329 citations2010: 375 citations2011: 333 citations2012: 348 citations2013: 444 citations2014: 433 citations2015: 579 citations2016: 663 citations2017: 734 citations2018: 760 citations2019: 2,842 citations2020: 3,312 citations2021: 2,968 citations2022: 2,283 citations2023: 1,795 citations2024: 2,907 citations2025: 1,435 citations2026: 40 citations1959–1962: no citations, so these years are not shown1965: no citations, so this year is not shown1972–1975: no citations, so these years are not shown1977: no citations, so this year is not shown1980–1981: no citations, so these years are not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,905 citing papers, 24.1% of this breakdownUnited Kingdom: 2,633 citing papers, 8% of this breakdownChina: 2,443 citing papers, 7.5% of this breakdownGermany: 2,203 citing papers, 6.7% of this breakdownItaly: 2,060 citing papers, 6.3% of this breakdownCanada: 1,535 citing papers, 4.7% of this breakdownFrance: 1,428 citing papers, 4.4% of this breakdownNetherlands: 1,095 citing papers, 3.3% of this breakdownJapan: 1,007 citing papers, 3.1% of this breakdownSpain: 967 citing papers, 3% of this breakdownSwitzerland: 867 citing papers, 2.6% of this breakdownAustralia: 831 citing papers, 2.5% of this breakdown
0%24.1%Other 23.8%

Fields

  • Medicine60.5%
  • Biochemistry, Genetics and Molecular Biology21.1%
  • Immunology and Microbiology8.8%
  • Neuroscience3.1%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Engineering0.9%
  • Other4.7%

Topics

  • Cardiac Valve Diseases and Treatments6.8%
  • Liver Disease Diagnosis and Treatment2.9%
  • Cardiovascular Function and Risk Factors2.8%
  • Aortic Disease and Treatment Approaches2.7%
  • Infective Endocarditis Diagnosis and Management2.3%
  • Immune Cell Function and Interaction2.1%
  • Other80.4%

Coauthors

All papers

Open in search
  1. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saraswathy V. Nochur, Marianne T. Sweetser, Pushkal Garg, Akshay Vaishnaw, Jared Gollob, Ole B. Suhr - New England Journal of Medicine 2018 cited by 2,918

  2. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation

    Authors: , , , , , , , , , , , , , , , - Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging 2017 cited by 3,440

  3. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Reardon - New England Journal of Medicine 2019 cited by 3,605

  4. The gut microbiota and host health: a new clinical frontier

    Authors: , , , , , , , , , , , , - Gut 2015 cited by 2,308

  5. Transcatheter Repair for Patients with Tricuspid Regurgitation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 855

  6. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shiangtung W. Jung, Brenda F. Baker, Elizabeth J. Ackermann, Morie A. Gertz, Teresa Coelho - New England Journal of Medicine 2018 cited by 1,422

  7. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. Pieter Kappetein - New England Journal of Medicine 2017 cited by 2,982

  8. Liver sinusoidal endothelial cells — gatekeepers of hepatic immunity

    Authors: , , - Nature Reviews Gastroenterology & Hepatology 2018 cited by 506

  9. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases

    Authors: , , , , , , , , , - Hepatology 2019 cited by 921

  10. Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

    Authors: , , , , , , , , , , , , , , , , - Amyloid 2022 cited by 379

  11. Transplantation of discarded livers following viability testing with normothermic machine perfusion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 471

  12. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 2,888

  13. Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , NEURO-TTRansform Investigators, Anna Mazzeo, Aikaterini Papagianni, Mazen M. Dimachkie, Ioannis Zaganas, Edward Gane, Marco Luigetti, Lucía Galán Dávila, Michelle M. Mezei, Juan González Moreno, Pascal Cintas, Davide Pareyson, Rebecca Traub, Julie Khoury, Conrado J. Estol, Merrilee Needham, David Adams, Michael Polydefkis, Thomas H. Brannagan, Vera Bril, Shahram Attarian, Marcelo Rugiero, B. Jane Distad, Eleni Zamba Papanicolaou, Kon‐Ping Lin, Merrill D. Benson, Morton Scheinberg - JAMA 2023 cited by 207

  14. Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ole B. Suhr - New England Journal of Medicine 2013 cited by 961

  15. Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver Borst, Caroline Wilson, Jack Leslie, Tracy O’Connor, Chris J. Weston, Abhishek Chauhan, David Adams, Lozan Sheriff, Ana Teijeiro, Marco Prinz, Ruzhica Bogeska, Natasha S. Anstee, Malte N. Bongers, Mike Notohamiprodjo, Tobias Geisler, Dominic J. Withers, Jerry Ware, Derek A. Mann, Hellmut G. Augustin, Alexandros Vegiopoulos, Michael D. Milsom, Adam J. Rose, Patricia F. Lalor, Josep M. Llovet, Roser Pinyol, Frank Tacke, Roland Rad, Matthias S. Matter, Nabil Djouder, Paul Kubes, Percy A. Knolle, Kristian Unger, Lars Zender, Bernhard Nieswandt, Meinrad Gawaz, Achim Weber, Mathias Heikenwälder - Nature Medicine 2019 cited by 381

  16. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 461

  17. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

    Authors: , , , , , , , , - Nature Reviews Drug Discovery 2010 cited by 931

  18. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions

    Authors: , , , , , , , , , , , , - European Heart Journal 2015 cited by 574

  19. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 424

  20. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher B. Gitter, Karen Meyer, Dana Roberts, Richard Bae, Paul Sorajja, Benjamin Sun, Judah Askew, Frazier Eales, Thomas Flavin, Mario Goessl, Vibhu R. Kshettry, M. Mooney, Wesley R. Pedersen, Anil Poulose, Pezhman Roohani, Robert Saeid Farivar, Richard Shronts, R Tarrel, Mark Young, Eddy Butkus, Kristin Pendleton, Robert D. Fry, Carl Heine, Kristin La Roe, Trung Tin Tran, Laura Weig, Himanshu Agarwal, Thomas Langdon, Ruby Satpathy, John Batter, Karen Bremer, Unajyothi Indukuri, Marijke Baas, Corry Oomes-Sistermans, Manola Smits, Carien Coenen, Inge Driesen, Lia Lauryssen, Margreet Poorter, Jeroen Schaap, Mohamed Bentala, Peter den Heijer, Jan Pieter, Michel Remmers, Marie Story, Paul M.M. van Erven, H Verbiest, Jeroen Vos, Michelle Bennett, Wendy Dunaj, Deborah Seaton, Deborah A. Waller, Bijoy K. Khandheria, Tanvir Bajwa, Daniel O’Hair, Arshad Ahmed, Suhail Allaqaband, Ayman Gheith, Elizabeth Marriott, Ajaz Qhavi, Varun Kumar Saxena, Akram Shhadeh, Paul Werner, Christine Yeomans, Lynn Bessette, Jessica Byrne, Heather Kieckhefer, Marleny Munoz, Elizabeth Russo, Jason Klein and 1,537 more - JAMA Cardiology 2022 cited by 178

  21. Transcatheter Aortic Valve Replacement Using a Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 1,035

  22. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease

    Authors: , , , - Nature Reviews Neurology 2019 cited by 438

  23. Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

    Authors: , , , , , , , , , , , , - Orphanet Journal of Rare Diseases 2015 cited by 322

  24. Primary sclerosing cholangitis

    Authors: , , , - The Lancet 2013 cited by 591